Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study
Open Access
- 16 August 2024
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 45, 101030
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid ImmunotherapiesJAMA Neurology, 2024
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma BiomarkersJAMA Neurology, 2023
- Clinical performance and robustness evaluation of plasma amyloid‐β42/40 prescreeningAlzheimer's & Dementia, 2022
- Associations of amyloid and neurodegeneration plasma biomarkers with comorbiditiesAlzheimer's & Dementia, 2021
- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's diseaseAlzheimer's & Dementia, 2021
- 2020 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2020
- Pre‐amyloid stage of Alzheimer's disease in cognitively normal individualsAnnals of Clinical and Translational Neurology, 2018
- Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.Journal of Lipid Research, 1990